PDL BioPharma Inc (NASDAQ:PDLI) - Share price - Overview

Stock Report

PDL BioPharma Inc PDLI

Last Price
$2.84

Day Change
-0.01|-0.35%

As of 17/11/2017
16:44:37 EST | USD
Minimum 15 Minutes Delay.

Last Close2.85
Day Range2.78 - 2.86
Mkt Cap438.30Mil
52-Wk Range1.93 - 3.55
Yield %-
ISINUS69329Y1047
Volume988,239
P/E5.68
P/S1.42
P/CF6.14

Share Price

Financials
201420152016
More ...
Income Statement
Revenue581.23590.45244.30
Operating Income546.31550.38129.40
Net Income322.24332.8063.61
Basic EPS2.042.040.39
Avg. Diluted Shares Outstanding173164164
Balance Sheet
Current Assets355.90282.71398.03
Non Current Assets606.45733.47817.36
Total Assets962.351,016.181,215.39
Current Liabilities187.9836.74130.32
Total Liabilities501.91320.23464.24
Total Equity460.44695.95751.14
Cash Flow
Operating Cash Flow292.28301.47101.72
Capital Expenditure-81.15-115.01-59.53
Free Cash Flow211.13186.4642.19

In millions, except "Basic EPS". Currency is USD.

Company Profile

PDL BioPharma Inc is engaged in the discovery of a new generation of targeted treatments for cancer and immunologic diseases. It focuses on intellectual property asset management, investing in new royalty bearing assets and maximizing value of its patent.

Sector

Healthcare

Industry

Biotechnology

Stock Style

Small-Value

Fiscal Year Ends

December

Employees

11
Key Stats
More ...
Price/Earning TTM5.70
Price/Book0.53
Price/Sales TTM1.50
Rev Growth (3 year avg)-17.99
EPS Growth (3 year avg)-
Operating Margin % TTM52.97
Net Margin % TTM26.04
ROE TTM8.79
Debt/Equity0.31
Dividends
PreviousLatest
More ...
Declared Date01/02/1602/05/16
Ex-Div02/03/1602/06/16
Paid11/03/1613/06/16
Amnt0.050.05
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.